Towards personalized therapies for genetic disorders of surfactant dysfunction

MP de Nieuwburgh, JA Wambach, M Griese… - Seminars in Fetal and …, 2023 - Elsevier
Genetic disorders of surfactant dysfunction are a rare cause of chronic, progressive or
refractory respiratory failure in term and preterm infants. This review explores genetic …

Management of suspected monogenic lung fibrosis in a specialised centre

R Borie, C Kannengiesser… - European …, 2017 - Eur Respiratory Soc
At least 10% of patients with interstitial lung disease present monogenic lung fibrosis
suspected on familial aggregation of pulmonary fibrosis, specific syndromes or early age of …

The common ABCA3E292V variant disrupts AT2 cell quality control and increases susceptibility to lung injury and aberrant remodeling

Y Tomer, J Wambach, L Knudsen… - … of Physiology-Lung …, 2021 - journals.physiology.org
ATP-binding cassette class A3 (ABCA3) is a lipid transporter that plays a critical role in
pulmonary surfactant function. The substitution of valine for glutamic acid at codon 292 …

[HTML][HTML] EMC3 coordinates surfactant protein and lipid homeostasis required for respiration

X Tang, JM Snowball, Y Xu, CL Na… - The Journal of …, 2017 - Am Soc Clin Investig
Adaptation to respiration at birth depends upon the synthesis of pulmonary surfactant, a lipid-
protein complex that reduces surface tension at the air-liquid interface in the alveoli and …

Functional Characterization of ATP-Binding Cassette Transporter A3 Mutations from Infants with Respiratory Distress Syndrome

JA Wambach, P Yang, DJ Wegner… - American journal of …, 2016 - atsjournals.org
Mutations in the ATP-binding cassette transporter A3 gene (ABCA3) result in severe
neonatal respiratory distress syndrome and childhood interstitial lung disease. As most …

Approaching clinical trials in childhood interstitial lung disease and pediatric pulmonary fibrosis

RR Deterding, EM DeBoer, MJ Cidon… - American journal of …, 2019 - atsjournals.org
Childhood interstitial lung disease (chILD) comprises a spectrum of rare diffuse lung
disorders. chILD is heterogeneous in origin, with different disease manifestations occurring …

Interstitial lung disease in children younger than 2 years

P Spagnolo, A Bush - Pediatrics, 2016 - publications.aap.org
Childhood interstitial lung disease (chILD) comprises a large and heterogeneous group of
rare disorders characterized by diffuse pulmonary infiltrates, restrictive lung physiology, and …

[HTML][HTML] Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine

A Alonso-Gonzalez, E Tosco-Herrera… - Frontiers in …, 2023 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a chronic, rare progressive lung disease, characterized
by lung scarring and the irreversible loss of lung function. Two anti-fibrotic drugs, nintedanib …

[HTML][HTML] Quantifying Functional Impairment of ABCA3 Variants Associated with Interstitial Lung Disease

X Yang, CK Rapp, Y Li, M Forstner… - International Journal of …, 2023 - mdpi.com
ATP-binding cassette subfamily A member 3 (ABCA3) is a lipid transporter within alveolar
type II cells. Patients with bi-allelic variants in ABCA3 may suffer from a variable severity of …

[HTML][HTML] Pulmonary alveolar proteinosis in children

A Bush, R Pabary - Breathe, 2020 - Eur Respiratory Soc
Pulmonary alveolar proteinosis (PAP) is an umbrella term for a wide spectrum of conditions
that have a very characteristic appearance on computed tomography. There is outlining of …